Innate Pharma S.A. carries a market capitalization of 165.27M, placing it among publicly traded companies globally.
| Market Cap | 165.27M |
| Enterprise Value | N/A |
Innate Pharma S.A.'s stock has declined approximately -17.37089% over the past 52 weeks. The 50-day moving average sits at 1.55, while the 200-day moving average is 1.79.
| Beta (5Y) | N/A |
| 52-Week Price Change | -17.37089% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 1.79 |
| Average Volume (20 Days) | N/A |